US Patent Issued to Rutgers, The State University of New Jersey on July 1 for "Pulmonary function treatment" (New Jersey Inventors)

ALEXANDRIA, Va., July 3 -- United States Patent no. 12,343,351, issued on July 1, was assigned to Rutgers, The State University of New Jersey (New Brunswick, N.J.).

"Pulmonary function treatment" was invented by Debra L. Laskin (Basking Ridge, N.J.), Jaclynn A. Meshanni (Hawthorne, N.J.), Grace L. Guo (Bridgewater, N.J.), Andrew J. Gow (Princeton, N.J.) and Jeffrey D. Laskin (Piscataway, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of treating reduced pulmonary function by administering an effective dose of a Farnesoid X Receptor (FXR) agonist, particularly obeticholic acid, is disclosed. Also disclosed is an in vivo animal model of lung injury and altered functioning, useful for identifying ...